AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
--------------------------------------------------------------------
Source: CNBC
Published: 2026-08-03 06:00 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Economy & Finance, Business & Economy
--------------------------------------------------------------------
Snippet:
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. competitor Bristol Myers Squibb, in a deal that would value the joint company at roughly $400 billion, the Financial Times reported on Sunday.
--------------------------------------------------------------------